Beximco Pharmaceuticals Limited R2WA.F · Stock Open Beximco Pharmaceuticals Limited in new tab
Beximco Pharmaceuticals Limited Analysis (R2WA.F)
Is Beximco Pharmaceuticals Limited a good investment? Beximco Pharmaceuticals Limited (R2WA.F) is currently trading at 0.4000 EUR.
In terms of valuation, the stock trades at a P/E ratio of 4.00. This relatively low multiple may signal that Beximco Pharmaceuticals Limited is undervalued compared to historical market norms.
For income investors, Beximco Pharmaceuticals Limited pays a dividend yield of 7.87%. With a payout ratio of 28%, the dividend appears sustainable.
Investor FAQ
Does Beximco Pharmaceuticals Limited pay a dividend?
Yes, it pays an annual dividend of 0.03 EUR (7.87% yield).
What asset class is Beximco Pharmaceuticals Limited?
Beximco Pharmaceuticals Limited is classified as a Stock. You can compare it against 5 other assets in the "Related Symbols" list on this page.
Company Profile
Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. Beximco Pharmaceuticals PLC. was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.03 EUR
|
| July 2, 2027 (estimated) | 0.0334 |
| ▸2026 |
0.03 EUR
|
| July 30, 2026 | 0.0334 |
| ▸2024 |
0.03 EUR
|
| Nov. 22, 2024 | 0.0335 |
| ▸2023 |
0.03 EUR
|
| Nov. 10, 2023 | 0.0318 |
| ▸2022 |
0.03 EUR
|
| Nov. 17, 2022 | 0.0332 |
| ▸2021 |
0.04 EUR
|
| Nov. 18, 2021 | 0.0397 |
| ▸2020 |
0.02 EUR
|
| Nov. 23, 2020 | 0.0177 |
| ▸2019 |
0.02 EUR
|
| Nov. 21, 2019 | 0.0161 |
| ▸2018 |
0.03 EUR
|
| Nov. 22, 2018 | 0.0135 |
| Nov. 21, 2018 | 0.0149 |
| ▸2017 |
0.01 EUR
|
| Nov. 13, 2017 | 0.0136 |
| ▸2016 |
0.02 EUR
|
| Oct. 28, 2016 | 0.0057 |
| May 10, 2016 | 0.0110 |
| ▸2015 |
0.01 EUR
|
| May 19, 2015 | 0.0101 |
| ▸2014 |
0.01 EUR
|
| May 14, 2014 | 0.0096 |
| ▸2009 |
0.00 EUR
|
| May 20, 2009 | 0.0047 |
| ▸2008 |
0.00 EUR
|
| July 2, 2008 | 0.0024 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Beximco Pharmaceuticals Limited | Jul 30, 2026 | Paid | 0.033402 EUR |
| Split Date | Split Ratio to 1 |
|---|---|
| June 27, 2008 | 10:1 |
| May 6, 2011 | 1.2 |
| May 18, 2012 | 1.21 |
| May 14, 2014 | 1.05 |
| May 19, 2015 | 1.05 |
| May 10, 2016 | 1.05 |
| Nov. 23, 2020 | 1.1 |
Community Discussion